CTKB in the 13F filings
Cytek Biosciences Inc · CUSIP 23285D109
- Quarter end
- 31 Dec 2025
- the date the book describes
- Filed
- 27 Oct 2026
- latest of these filings; the earliest 10 Feb 2026
- Managers listing it
- 20
- at least, of 95 tracked, among listed positions
- Comparable managers
- 92
- filed both Q3 2025 and Q4 2025; 0 listed it in both
- Shares listed
- 9,704,254
- combined, among listed positions
- Reported value
- $49m
- combined, at the quarter end
Among the 92 comparable managers: 10 buyers (opened or added shares) and 15 sellers (trimmed or exited), at least, among listed positions. Their net change in shares was -1,829,720.
Managers listing CTKB in Q4 2025
20 of 20 holders
Largest increases and reductions, by shares
Increases
- Millennium Management LLCexisting position · 4,752,447 shares now+1,334,065
- D. E. Shaw & Co.existing position · 263,126 shares now+142,104
- Acadian Asset Management LLCexisting position · 674,475 shares now+108,902
- Citadel Advisors LLCexisting position · 166,754 shares now+84,450
- Fidelity (FMR LLC)existing position · 234,072 shares now+53,286
Reductions
- Wellington Management Group LLPexisting position · 764,279 shares now-1,776,767
- Jane Street Group LLCexisting position · 78,758 shares now-278,267
- AQR Capital Management LLCexisting position · 743,455 shares now-276,435
- Two Sigma Investments LPexisting position · 30,032 shares now-145,727
- Susquehanna International Group LLPexisting position · 48,103 shares now-144,750
New positions and exits
New (1)
Exited (6)
- Tudor Investment Corpwas $867k
- Squarepoint Ops LLCwas $550k
- Marshall Wace LLPwas $466k
- ExodusPoint Capital Management LPwas $219k
- Two Sigma Advisers LPwas $214k
- Brevan Howard Capital Management LPwas $165k
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q1 2022 | 1 | $597k | n.a. | n.a. |
| Q2 2022 | 2 | $22m | n.a. | n.a. |
| Q3 2022 | 1 | $463k | n.a. | n.a. |
| Q4 2022 | 1 | $320k | n.a. | n.a. |
| Q1 2023 | 1 | $747k | n.a. | n.a. |
| Q2 2023 | 1 | $987k | n.a. | n.a. |
| Q4 2025 | 1 | $464k | 10 | 15 |
| Q1 2026 | 1 | $380k | 9 | 12 |
| Q2 2026 | 1 | $385k | 19 | 4 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
CTKB and LLY →CTKB and JNJ →CTKB and VRTX →Choose a stock to compare with CTKB →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own CTKB, latest filings →Back to the 13F Explorer →